Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

  •   Table of Contents

Download Guidelines

Appendix B: Panel Roster and Financial Disclosures


Last Updated: January 1, 2020; Last Reviewed: August 1, 2019

Member Financial Disclosure
Company Relationship
Dhanireddy, Shireesha* University of Washington School of Medicine None N/A
Neblett Fanfair, Robyn Centers for Disease Control and Prevention None N/A
Ortiz, Justin University of Maryland School of Medicine Pfizer Speaking Compensation, Advisory Board
Peters, Philip Centers for Disease Control and Prevention None N/A
Solomon, Daniel Harvard University None N/A

* Group lead

Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from August 1, 2018, through August 1, 2019.

Download Guidelines